Table 3.
Comparison of general clinical data between the good prognosis group and the poor prognosis group.
| Variables | The good prognosis group (n = 391) | The poor prognosis group (n = 111) | P |
|---|---|---|---|
| Gender (male, %) | 225 (57) | 59 (53) | 0.570 |
| Age [years old, M (Q1, Q3)] | 69.00 (65.00, 77.50) | 75.00 (68.50, 83.50) | < 0.001 |
| Systolic blood pressure (mmHg, 𝑥̅±𝑠) | 145.08 ± 20.99 | 149.55 ± 21.58 | 0.054 |
| Height [m, M (Q1, Q3)] | 1.66 (1.60, 1.71) | 1.64 (1.60, 1.70) | 0.181 |
| Body weight [Kg, M (Q1, Q3)] | 67.00 (60.00, 75.00) | 65.00 (60.69, 70.00) | 0.089 |
| BMI [Kg/m2, M (Q1, Q3)] | 24.49 (22.58, 26.49) | 23.66 (22.48, 26.03) | 0.130 |
| Smoking, n (%) | 151 (39) | 31 (28) | 0.050 |
| Atrial fibrillation, n (%) | 23 (6) | 13 (12) | 0.058 |
| White blood cell count [×109/L, M (Q1, Q3)] | 6.36 (5.28, 7.75) | 7.47 (5.72, 8.92) | < 0.001 |
| Hemoglobin [g/L, M (Q1, Q3)] | 134 (124, 144) | 134 (122, 144) | 0.585 |
| Platelet count [×109/L, M (Q1, Q3)] | 213.00 (176.50, 256.50) | 212.00 (181.50, 253.50) | 0.899 |
| Neutral particle count [×109/L, M (Q1, Q3)] | 4.14 (3.09, 5.22) | 4.90 (3.76, 6.53) | < 0.001 |
| Lymphocyte [×109/L, M (Q1, Q3)] | 1.60 (1.23, 2.04) | 1.37 (1.04, 1.77) | 0.002 |
| Hs-CRP [mg/L, M (Q1, Q3)] | 1.51 (0.55, 3.48) | 2.72 (1.38, 8.72) | < 0.001 |
| Creatinine [μmol/L, M (Q1, Q3)] | 68.00 (57.40, 82.00) | 65.00 (52.65, 83.35) | 0.186 |
| Uric acid [μmol/L, M (Q1, Q3)] | 306.00 (254.24, 358.50) | 313.40 (236.00, 389.50) | 0.804 |
| Albumin [g/L, M (Q1, Q3)] | 41.60 (39.02, 44.20) | 40.54 (37.67, 43.15) | 0.003 |
| Total cholesterol, [mmol/L, M (Q1, Q3)] | 4.29 (3.52, 5.23) | 4.18 (3.36, 5.12) | 0.393 |
| Triglyceride [mmol/L, M(Q1,Q3)] | 1.29 (0.97, 1.75) | 1.21 (0.90, 1.65) | 0.251 |
| HDL [mmol/L, M (Q1, Q3)] | 1.08 (0.93, 1.25) | 1.06 (0.90, 1.29) | 0.496 |
| LDL [mmol/L, M (Q1, Q3)] | 2.36 (1.80, 3.06) | 2.36 (1.71, 3.00) | 0.605 |
| PNI [M (Q1, Q3)] | 49.86 (46.41, 53.06) | 47.43 (44.30, 50.98) | < 0.001 |
| GNRI [M (Q1, Q3)] | 109.47 (103.76, 115.08) | 106.51 (100.87, 111.98) | 0.004 |
| NLR [M (Q1, Q3)] | 2.52 (1.78, 3.47) | 3.24 (2.32, 5.41) | < 0.001 |
| LMR [M (Q1, Q3)] | 3.88 (2.91, 5.18) | 3.34 (2.26, 4.37) | < 0.001 |
| NPS, n (%) | < 0.001 | ||
| 0 | 43 (11) | 6 (5) | |
| 1 | 99 (25) | 20 (18) | |
| 2 | 117 (30) | 26 (23) | |
| 3 | 99 (25) | 35 (32) | |
| 4 | 33 (8) | 24 (22) | |
| CONUT Score [M (Q1, Q3)] | 2 (1, 3) | 2 (1, 3) | < 0.001 |
| HALP Score [M (Q1, Q3)] | 41.60 (31.13, 55.19) | 34.46 (25.50, 47.45) | < 0.001 |
BMI, Body Mass Index; HDL, High Density Lipoprotein; LDL, Low Density Lipoprotein; PNI, Prognostic Nutritional Index; HALP, Hemoglobin, Albumin, Lymphocyte, and Platelet Score; NPS, Naples Prognostic Score; GNRI, Geriatric Nutritional Risk Index; CONUT, Controlling Nutritional Status; NLR, Neutrophil-Lymphocyte Ratio; LMR, Lymphocyte Monocyte Ratio.